COST-EFFECTIVENESS OF TORACOTOMY VERSUS VIDEOTORACOSCOPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN STADIUM

被引：0
|
作者：
Guevara, G. A. [1 ]
Parody, E. [1 ]
Aguirre, A. F. [2 ]
机构：
[1] Icesi Univ, Cali, Colombia
[2] Ctr Social Protect & Hlth Econ, Cali, Colombia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN34
引用
收藏
页码：A821 / A821
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of smoking cessation in patients with non-small cell lung cancer
    Kunde, Katharina
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2023, 28 (04): : 150 - 151
  • [2] Cost-effectiveness of diagnostic interventions. Non-small cell lung cancer
    Langer, A.
    [J]. ONKOLOGE, 2010, 16 (10): : 992 - +
  • [3] MODIFIED FRACTIONATION RADIOTHERAPY VERSUS CONVENTIONAL RADIOTHERAPY FOR UNRESECTED NON-SMALL CELL LUNG CANCER PATIENTS: A COST-EFFECTIVENESS ANALYSIS
    De Ruysscher, D.
    Ramaekers, B. L. T.
    Joore, M. A.
    Lueza, B.
    Bonastre, J.
    Mauguen, A.
    Pignon, J.
    Le Pechoux, C.
    Grutters, J. P.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 397 - 397
  • [4] Cost-effectiveness of Surveillance versus Prophylactic Cranial Irradiation for Locally Advanced Non-Small Cell Lung Cancer
    Huang, T. Q.
    Smith, C. P.
    Adefres, B.
    Lee, P.
    Raldow, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E393 - E393
  • [5] Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer
    Liang, Xueyan
    Chen, Xiaoyu
    Li, Huijuan
    Li, Yan
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden
    Criss, Steven D.
    Palazzo, Lauren
    Watson, Tina R.
    Paquette, Adelle M.
    Sigel, Keith
    Wisnivesky, Juan
    Kong, Chung Yin
    [J]. PLOS ONE, 2020, 15 (01):
  • [7] Cost-effectiveness of additional serplulimab to chemotherapy in metastatic squamous non-small cell lung cancer patients
    Zheng, Hanrui
    Zeng, Ya
    Wen, Feng
    Hu, Ming
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer
    Schreyoegg, Jonas
    Weller, Julia
    Stargardt, Tom
    Herrmann, Ken
    Bluemel, Christina
    Dechow, Tobias
    Glatting, Gerhard
    Krause, Bernd J.
    Mottaghy, Felix
    Reske, Sven N.
    Buck, Andreas K.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11): : 1668 - 1675
  • [9] Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer
    Czarnecka-Kujawa, Katarzyna
    Rochau, Ursula
    Siebert, Uwe
    Atenafu, Eshetu
    Darling, Gail
    Waddell, Thomas Kenneth
    Pierre, Andrew
    De Perrot, Marc
    Cypel, Marcelo
    Keshavjee, Shaf
    Yasufuku, Kazuhiro
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (06): : 1567 - 1576
  • [10] COST-EFFECTIVENESS OF MULTIPLEXED PREDICTIVE BIOMARKER SCREENING IN NON-SMALL CELL LUNG CANCER
    Romanus, D.
    Cardarella, S.
    Cutler, D.
    Landrum, M. B.
    Lindeman, N.
    Gazelle, G. S.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A204 - A204
12345